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Introduction:
It has previously been shown that a nitric oxide scavenger, carboxy-2-phenyl-4,4,5,5-tetramethylimidazoline-l-oxy-l-3-oxide (carboxy-PTIO), improve tissue injury in rats after experimental focal cerebral ischemia when given before the ischemic insult. 1,2 Carboxy -PTIO has also been shown to improve damaged hepatocellular enery metabolism in the lipopolysaccharide-induced endotoxic rabbits. 3 Accordingly, we hypothesized the mechanism is thought to be improving the energy supply to the neuronal tissue at risk of ischemia. In addition to simulate the clinical scenario that stroke patient often seeks medical attention hours after the ischemic episode, the present study examine whether delayed treatment with this agent could also be beneficial in the same model of permanent middle cerebral artery occlusion (MCAO) in the mice.
Methods and Materials:
Under anesthetized 1-2 % halothane in 70% N 2 O/ 30% O 2 , fifty-four male C57BL/6J mice (weighing 24-30gm) underwent a permanent MCAO by a standard intraluminal filament occlusion technique. 4 Briefly, the bifurcation of the right common carotid artery was exposed under an operative microscope. A 6-0 nylon suture, with its tip rounded by heating over a flame and subsequently coated with silicone, was then advanced 7.5-8.5 mm from the external into the internal carotid artery until the tip occluded the origin of the MCA.
Ischemia was ensured by a sharp decrease of local cortical blood flow (LCBF) by Laser Doppler flowmetry (LDF, Laserflo BMP2, Vasamedics, St. Paul, MN). All mice received a single intraperitoneal injection of carboxy-PTIO 0.6 mg/kg: in group A, n=6, at 0.5 hr; group B, n=6, at 2 hr; group C, n=8, at 3 hrs; and group D, n=8, at 4 hrs after permanent MCAO.
Sacrifice was performed 22-24 h after permanent MCA occlusion by decapitation. The brain was then rapidly removed, cut into 2 mm coronal sections using a mouse brain matrix (RBM 2000C, ASI Instrument, Inc., Warren, MI) and stained according to the standard 2, 3, 5-triphenyltetrazolium chloride (TTC) method. 5, 6 The infarction volumes were determined by a quantitative image analysis of TTC stained brain sections.
Results:
A single intraperitoneal injection of carboxy-PTIO (0.6 mg/kg) given at either 0. 
Conclusion:
Present study demonstrated that delayed treatment with carboxy-PTIO improve brain injury even 4 hours after the ischemic insult. The mechanism is not clear from this study but it may relate to the scavenging effects of nitric oxide related production of toxic oxidants and free radicals after ischemic injury. Further investigation is needed for its potential role in the clinical use. 
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Introduction:
It has previously been shown that a nitric oxide scavenger, carboxy-2-phenyl-4,4,5,5-tetramethylimidazoline-l-oxy-l-3-oxide (carboxy-PTIO), improve tissue injury in rats after experimental focal cerebral ischemia when given before the ischemic insult. The mechanism is thought to be improving the energy supply to the neuronal tissue at risk of ischemia. To simulate the clinical scenario that stroke patient often seeks medical attention hours after the ischemic episode, the present study examine whether delayed treatment with this agent could also be beneficial in the same model of permanent middle cerebral artery occlusion (MCAO) in the mice.
Methods and Materials:
Under halothane anesthesia, male C57BL/6J mice (weighing 24-30gm) underwent a permanent MCAO by a standard intraluminal filament occlusion technique. MCAO was confirmed by using Laser Doppler flowmetry. All mice received a single intraperitoneal injection of carboxy-PTIO 0.6 mg/kg: in group A, n=6, at 0.5 hr; group B, n=6, at 2 hr; group C, n=8, at 3 hrs; and group D, n=8, at 4 hrs after permanent MCAO. Twenty-four hours after the MCAO infarction volumes were determined by a quantitative image analysis of 2, 3, 5-Triphenyltetrazolium (TTC) stained brain sections.
Results:
A single intraperitoneal injection of carboxy-PTIO (0.6 mg/kg) given at either 0.5, 2, 3, or 4 hours after permanent MCAO significantly (P < 0.05) reduced infarction volume (mean ±SD) 21.6±1.5%; 24.8±3.2%; 28.2±2.6%; and 26.1±2.6 respectively, compared with the pooled time-and dose-compatible placebo controls (39.0±2.0%, n=26).
Conclusion:
Present study demonstrated that delayed treatment with carboxy-PTIO improve brain injury even 4 hours after the ischemic insult. The mechanism is not clear from this study but it may relate to the scavenging effects of nitric oxide related production of toxic oxidants and free radicals after ischemic injury. Further investigation is needed for its potential role in the clinical use.
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